FDA halts Novavax trial of Covid-flu combination jab after participant develops nerve damage

By Editor Two on October 17, 2024   Exclusives, Rest of The Best, Top Stories, U.S., U.S. Health, World Links, World Tribune  

by WorldTribune Staff, October 17, 2024 Contract With Our Readers The FDA has stopped the trial of Novavax’s experimental Covid-flu combination vaccine and its standalone flu shot after a trial participant reported nerve damage. The participant developed motor neuropathy — a disease affecting the nerves that control muscles after receiving the Covid-flu combination shot in […]